Ladenburg Thalmann Financial Services’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-301	Closed	-$52K	–	4927
2015 Q1	$52K	Sell	301 -14,937	-98%	-$2.19M	﹤0.01%	2536
2014 Q4	$1.75M	Sell	15,238 -8,461	-36%	-$1.02M	0.04%	399
2014 Q3	$3.7M	Sell	23,699 -1,819	-7%	-$264K	0.1%	178
2014 Q2	$3.15M	Buy	25,518 +5,108	+25%	+$565K	0.09%	195
2014 Q1	$2.12M	Sell	20,410 -275	-1%	-$28.2K	0.06%	258
2013 Q4	$1.86M	Buy	20,685 +299	+1%	+$23.8K	0.06%	270
2013 Q3	$1.36M	Buy	20,386 +212	+1%	+$14.6K	0.05%	320
2013 Q2	$1.33M	Buy	+20,174	New	+$1.15M	0.05%	314

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Ladenburg Thalmann Financial Services's SLXP Position: Q2 2015 in Review

Ladenburg Thalmann Financial Services sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 301 shares — an estimated $52K sold.

Ladenburg Thalmann Financial Services first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $3.7M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Ladenburg Thalmann Financial Services reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 301 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $52K.
Ladenburg Thalmann Financial Services first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Ladenburg Thalmann Financial Services's SALIX PHARMACEUTICALS LTD DEL position peaked at $3.7M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q2 2015, filed 14 Aug 2015.